Loading...

Home
ETF
KLTO

KLTO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

KLTO News

Klotho CEO Dr. Joseph Sinkule to Present at Biotech Showcase on January 13, 2026

Jan 08 2026Newsfilter

Coinbase CEO Armstrong Invests in NewLimit, Secures $45 Million Funding

Jan 06 2026Benzinga

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Nov 07 2025PRnewswire

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Oct 16 2025PRnewswire

Klotho Neurosciences Declares Letter of Intent No Longer Valid

Oct 07 2025Newsfilter

CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar

Sep 09 2025PRnewswire

Le PDG de Klotho Neurosciences participera à la conférence inaugurale et au séminaire scientifique

Sep 09 2025PRnewswire

CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil

Sep 09 2025PRnewswire

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Sep 08 2025PRnewswire

Docusign Shares Surge Over 8%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 05 2025Benzinga

Klotho Neurosciences Shares Shareholder Update on Recent Achievements While Preparing to Tackle $8 Billion Neurodegenerative Disease Market

Aug 18 2025Newsfilter

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 26 2025Yahoo Finance

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 24 2025Newsfilter

Klotho Neurosciences Partners With AAVnerGene To Accelerate Cost-Effective Gene Therapy Development

Jul 23 2025NASDAQ.COM

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Jul 22 2025Newsfilter

Klotho Clears Nasdaq Hurdle—KLTO Stock Remains On The Big Board

Jul 16 2025Benzinga